fasudil and Hyperemia
fasudil has been researched along with Hyperemia in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Hyperemia: The presence of an increased amount of blood in a body part or an organ leading to congestion or engorgement of blood vessels. Hyperemia can be due to increase of blood flow into the area (active or arterial), or due to obstruction of outflow of blood from the area (passive or venous).
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiovascular diseases are associated with chronic activation of Rho-associated kinases (ROCKs) and endothelial dysfunction." | 1.37 | Rho-associated kinase activity, endothelial function, and cardiovascular risk factors. ( Chayama, K; Fujii, Y; Fujimura, N; Hata, T; Hidaka, T; Higashi, Y; Idei, N; Kato, H; Kihara, Y; Liao, JK; Maruhashi, T; Mikami, S; Noma, K; Soga, J, 2011) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Soga, J | 1 |
| Noma, K | 1 |
| Hata, T | 1 |
| Hidaka, T | 1 |
| Fujii, Y | 1 |
| Idei, N | 1 |
| Fujimura, N | 1 |
| Mikami, S | 1 |
| Maruhashi, T | 1 |
| Kihara, Y | 1 |
| Chayama, K | 1 |
| Kato, H | 1 |
| Liao, JK | 1 |
| Higashi, Y | 1 |
Other Studies
1 other study available for fasudil and Hyperemia
| Article | Year |
|---|---|
Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adult; Aged; Blood Pressure; Blotting, Western; Body | 2011 |